Entourage_logo (002).jpg
Entourage Health Reports Third Quarter 2023 Financial Results and Posts $12.2 Million in Total Revenue
November 28, 2023 07:45 ET | Entourage Health Corp.
Entourage sees the benefits of transitioning from cultivation and reports over $10 million to date in annualized cost savings.Gross Profit Before Fair Value Changes has surged to $2.4 million,...
Entourage_logo (002).jpg
Entourage Health to Host Third Quarter 2023 Financial Results Call on November 28
November 08, 2023 07:00 ET | Entourage Health Corp.
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage_logo (002).jpg
Entourage Health Reports Second Quarter 2023 Financial Results
August 30, 2023 07:41 ET | Entourage Health Corp.
The Company achieved a total revenue of $13.3 million, driven by an 8% increase in adult-use revenue and a significant 45% increase in pre-roll revenue year-over-yearGross Profit Before Fair Value...
Entourage_logo (002).jpg
Entourage Health to Host First Quarter 2023 Earnings Conference Call
May 15, 2023 07:30 ET | Entourage Health Corp.
Company financials to be filed after market on May 29, 2023, and operational outlook to be provided during call, including milestones achieved. Company announces issuance of 1,423,057 common shares...
Entourage_logo (002).jpg
Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues
May 01, 2023 19:52 ET | Entourage Health Corp.
Record net medical revenue of $17.4 million for 2022, representing 16% growthEntourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022Upsized...
Entourage_logo (002).jpg
Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results
April 21, 2023 16:00 ET | Entourage Health Corp.
TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
Entourage_logo (002).jpg
Entourage Health Announces Timing of Fiscal Year End 2022 Conference Call for April 28
April 14, 2023 07:35 ET | Entourage Health Corp.
TORONTO, April 14, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
Entourage_logo (002).jpg
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue
November 15, 2022 08:20 ET | Entourage Health Corp.
Company signs three-year supply agreement with HEXO Corp. to buy bulk cannabis for its expanding retail distribution and increased medical offeringsEntourage to transition away from cultivation as it...
Entourage_logo (002).jpg
Entourage Health to Host Third Quarter 2022 Financial Results Call on November 15
November 08, 2022 07:30 ET | Entourage Health Corp.
TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage_logo (002).jpg
Entourage Health Reports Second Quarter 2022 Financial Results
August 29, 2022 09:49 ET | Entourage Health Corp.
TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...